Disclosure 0001193125-26-363812-1

SEC FORM 4

$1,239,000.00

Kura Oncology, Inc. (KURA)

Purchase of 100,000 shares at $12.39 per share.

Reporting Person WILSON TROY EDWARD · Officer Title President and CEO · Transaction Code P

Traded Aug 24, 2026 · Disclosed Aug 24, 2026

Source: SEC Form 4 · 0001193125-26-363812 · filed 2026-08-24 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Kura Oncology, Inc. (KURA)." Disclosed 2026-08-24. https://desqlong.com/cards/0001193125-26-363812-1 (retrieved 2026-09-26).